Helena Janols

1.5k citations
21 papers · 537 indexed · h-index 11
Topics
Immune Response and Inflammation (7 papers)Immune cells in cancer (5 papers)COVID-19 and Mental Health (4 papers)
Partner nations
SwedenGermanyEthiopia

In The Last Decade

Helena Janols

19 papers receiving 531 citations

Peers

Helena Janols
Comparison fields: 5 of 85
  • Immunology 306
  • Molecular Biology 119
  • Oncology 109
  • Epidemiology 78
  • Neurology 62
Replace Julien Carvelli with:
Julien Carvelli France
Ivette Buendía-Roldán Mexico
Nelli Heikkilä Finland
Salma A. Rizo-Téllez Mexico
Gregory Bagby United States
Antoaneta A. Toncheva Germany
Alberto Utrero‐Rico Spain
Emma Erlich United States
Mohsen Rokni Iran
Helena Janols relative to Julien Carvelli France Julien Carvelli's profile →
Citations per field
00.5×10×20×30×41×
Julien Carvelli · 1×
Citations per year

Countries citing papers authored by Helena Janols

Since Specialization
Citations

This map shows the geographic impact of Helena Janols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Janols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Janols more than expected).

Fields of papers citing papers by Helena Janols

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Janols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Janols. The network helps show where Helena Janols may publish in the future.

Co-authorship network of co-authors of Helena Janols

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Janols. A scholar is included among the top collaborators of Helena Janols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Janols. Helena Janols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 3
4 4
5 24
6 1
7 29
8 6
9 19
10 1
11 115
12 5
13 121
14 13
15 21
16 20
17 104
18 9
19 17
20 24

About Helena Janols

Helena Janols is a scholar working on Critical Care and Intensive Care Medicine, Immunology and Infectious Diseases, having authored 21 papers that have together received 537 indexed citations. Recurring topics across this work include Immune Response and Inflammation (7 papers), Immune cells in cancer (5 papers) and COVID-19 and Mental Health (4 papers). The work is most often cited by research in Immunology (306 citations), Critical Care and Intensive Care Medicine (45 citations) and Neurology (62 citations). Helena Janols has collaborated with scholars based in Sweden, Germany and Ethiopia. Frequent co-authors include Anders Bredberg, Marlene Wullt, Karin Leandersson, Caroline Bergenfelz, Lisa Rydén, Karin Jirström, Sven Björnsson, Sabina Janciauskiene, Elin Ekström and Roni Allaoui. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026